The Oxford Science Park
Ellison Institute submits planning application for new facility at Oxford Science Park
The facility has been designed by Foster + Partners and is devoted to reimagining and redefining cancer treatment whilst enhancing overall human health and global health policy.
The Oxford Science Park aquires the Hinshelwood Building to expand capacity
The transaction is part of The Oxford Science Park’s ongoing investment programme, providing the support infrastructure for growing companies as they address global health and environmental challenges.
Companies move into refurbished Hayakawa Building at The Oxford Science Park
New occupiers, CyanoCapture and Ochre Bio, are joining MiroBio, MoA Technology and Oxford Nanopore Technologies, who are expanding their footprint on the Park, as well as Circassia, which is relocating from another building.
Exscientia expands headquarters at The Oxford Science Park
The company, which initially occupied c7,800 sq ft in the Schrödinger Building is increasing capacity for its technology teams by expanding to 21,000 sq ft of facilities.
Immunotherapy company Etcembly joins AI firms at The Oxford Science Park
The machine learning immunotherapy discovery company joins a group of thriving companies which use artificial intelligence techniques in their research.
Oxford biotech firm plans clinical trial for next-generation COVID-19 vaccine
The studies will allow the company to assess the ability of its next-generation vaccine to boost the immune response against current and potential future strains of COVID-19.
Velocys technology powers first commercial flight to use wood chip fuel
Japan Airlines flight (JAL #515) from Tokyo to Sapporo completed the flight on 17 June using sustainable aviation fuel (SAF) from woody biomass residue feedstock produced by the company’s proprietary technology.
ATDBio establishes molecular diagnostics lab at The Oxford Science Park
The 745 sq ft molecular diagnostics research and quality control lab will support its customers in developing improved molecular diagnostics for COVID-19 and other pathogens.
Kadans acquires Sherard Building on The Oxford Science Park
The c.28,000 sq ft building, let in its entirety to the Oxford Science Innovation (OSI), was acquired from MRP, the property arm of construction firm McAleer & Rushe.
MoA Technology moves to The Oxford Science Park
MoA Technology has moved to the Bellhouse Building, the most recently completed building in the Magdalen Centre, one of the largest innovation centres in the UK.
Magdalen College seeks partner for The Oxford Science Park development
Its 14.75 acres of development land has the capacity for 420,000 sq ft to support the growth of existing occupiers and enable new companies to join the thriving campus.
Enara Bio relocates to the Bellhouse Building at The Oxford Science Park
The move from the Oxford BioEscalator to one of the UK’s largest biomedical innovation centres is in preparation for its future growth and ambition to transform cancer care.
